{"drugs":["Hepatitis A Inactivated\/Hepatitis B Recombinant Vaccine","Twinrix"],"mono":{"0":{"id":"926422-s-0","title":"Generic Names","mono":"Hepatitis A Inactivated\/Hepatitis B Recombinant Vaccine"},"1":{"id":"926422-s-1","title":"Dosing and Indications","sub":{"0":{"id":"926422-s-1-4","title":"Adult Dosing","mono":"<b>Hepatitis A; Prophylaxis - Hepatitis B; Prophylaxis:<\/b> 1 mL IM x 3 doses at 0, 1, and 6 months OR 1 mL IM x 4 doses (on days 0, 7, and between 21 to 30, followed by a booster dose at month 12) "},"1":{"id":"926422-s-1-5","title":"Pediatric Dosing","mono":"safety and effectiveness in pediatric patients younger than 18 years have not been established "},"3":{"id":"926422-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Hepatitis A; Prophylaxis - Hepatitis B; Prophylaxis<br\/>"}}},"3":{"id":"926422-s-3","title":"Contraindications\/Warnings","sub":[{"id":"926422-s-3-9","title":"Contraindications","mono":"allergic reaction, severe (eg, anaphylaxis), after a previous dose of any hepatitis A- or hepatitis B-containing vaccine, or to any vaccine component, including yeast and neomycin <br\/>"},{"id":"926422-s-3-10","title":"Precautions","mono":"<ul><li>acute illness with  or without fever, moderate or severe; defer vaccination unless the benefit of protection outweighs the risk of an adverse reaction<\/li><li>immunocompromised patients, including those receiving concomitant immunosuppressive therapy; diminished immune response may occur<\/li><li>latex sensitivity; rubber plunger and\/or tip cap of need&le;ss prefilled syringes may contain natural latex rubber<\/li><li>syncope, possibly accompanied by transient neurological signs (eg, visual disturbance, paresthesia, tonic-clonic limb movements), may occur<\/li><li>report suspected adverse effects to the Vaccine Adverse Events Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov<\/li><\/ul>"},{"id":"926422-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"926422-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"926422-s-4","title":"Drug Interactions","sub":{"1":{"id":"926422-s-4-14","title":"Major","mono":"<ul>Cyclosporine (theoretical)<\/ul>"}}},"5":{"id":"926422-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Injection site induration (1% to 10%), Injection site inflammation (8% to 11%), Injection site pain (35% to 41%), Swelling at injection site (4% to 6%)<\/li><li><b>Gastrointestinal:<\/b>Diarrhea (4% to 6%)<\/li><li><b>Neurologic:<\/b>Headache (13% to 22%)<\/li><li><b>Respiratory:<\/b>Upper respiratory infection (1% to 10%)<\/li><li><b>Other:<\/b>Fatigue (11% to 14%)<\/li><\/ul><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Syncope (less than 1%)<\/li><li><b>Gastrointestinal:<\/b>Necrotizing pancreatitis, acute<\/li><li><b>Hematologic:<\/b>Thrombocytopenia, Thrombocytopenic purpura<\/li><li><b>Hepatic:<\/b>Hepatitis<\/li><li><b>Immunologic:<\/b>Anaphylaxis, Herpes zoster, Hypersensitivity reaction<\/li><li><b>Neurologic:<\/b>Bell's palsy, Encephalitis, Encephalopathy, Guillain-Barr  syndrome, Meningitis, Multiple sclerosis, Myelitis, Paralysis, Seizure, Transverse myelopathy syndrome<\/li><li><b>Respiratory:<\/b>Dyspnea<\/li><li><b>Other:<\/b>Angioedema<\/li><\/ul>"},"6":{"id":"926422-s-6","title":"Drug Name Info","sub":{"0":{"id":"926422-s-6-17","title":"US Trade Names","mono":"Twinrix<br\/>"},"2":{"id":"926422-s-6-19","title":"Class","mono":"Vaccine<br\/>"},"3":{"id":"926422-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"926422-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"926422-s-7","title":"Mechanism Of Action","mono":"Hepatitis A (inactivated) and hepatitis B vaccine (recombinant) is a bivalent vaccine that confers active immunity against infection caused by hepatitis A virus, all known hepatitis B virus subtypes and hepatitis D, which only occurs in the presence of hepatitis B. However, it does not provide immunity against other hepatotropic viruses. It contains the HM175 strain of inactivated hepatitis A virus and purified hepatitis B virus surface antigen (HBsAg).<br\/>"},"9":{"id":"926422-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>do NOT give IV, subQ, or intradermally,<br\/><\/li><li><b>Intramuscular<\/b><br\/><ul><li>shake well before use<\/li><li>administer IM in deltoid region; do not administer in the gluteal region<\/li><\/ul><\/li><\/ul>"},"11":{"id":"926422-s-11","title":"How Supplied","mono":"<b>Twinrix<\/b><br\/>Intramuscular Suspension: (Hepatitis A Vaccine, Inactivated - Hepatitis B Vaccine Recombinant) 720 EL U\/ML-20 MCG\/ML<br\/>"},"13":{"id":"926422-s-13","title":"Clinical Teaching","mono":"<ul><li>This vaccine is used to prevent and not to treat hepatitis A or B.<\/li><li>Vaccine may cause diarrhea, nausea, headache, fatigue, or fever.<\/li><li>Review dosing schedule with patient.<\/li><\/ul>"}}}